The FDA recently approved the Gadolinium dye EOVIST to be used to help detect liver problems.  This makes EOVIST somewhat unique because it’s approved to target problems with specific organs.  Like all Gadolinium dyes, this one also carries an FDA black box warning:

“Gadolinium-based contrast agents increase the risk of Nephrogenic Systemic Fibrosis in patients